They demonstrated that both in vivo and in vitro, downregulation of TSPAN4 could inhibit the growth of gastric cancer cells, suggesting that TSPAN4 might play a role in slowing the progression of gastric cancer (Qi et al., 2018). Here, TSPAN4 is linked to gastric cancer.